Join series hosts Dr. Jim Gavin, Clinical Professor of Medicine at Emory University and Chief Medical Officer at Healing Our Village, in Atlanta, GA; Dr. Jennifer Goldman, Professor of Pharmacy at Massachusetts College of Pharmacy, in Boston, MA, and Clinical Pharmacist at Well Life Medical, in Peabody, MA, and other fellow leaders in the field of diabetes as they tackle some of the challenges we face when treating T2D. Topics of discussion include the disease state of T2D, the role of GLP-1 in glucose regulation, guidelines on early use of GLP-1 RAs in T2D treatment, as well as the mechanism of action, dosing and administration, efficacy and safety profiles, handling and storage, and education of patients and pharmacists for a once-daily GLP-1 RA for adults with T2D.
This podcast series is sponsored by Novo Nordisk and is intended for clinicians.
All content for The 411 on a GLP-1 is the property of Novo Nordisk and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Join series hosts Dr. Jim Gavin, Clinical Professor of Medicine at Emory University and Chief Medical Officer at Healing Our Village, in Atlanta, GA; Dr. Jennifer Goldman, Professor of Pharmacy at Massachusetts College of Pharmacy, in Boston, MA, and Clinical Pharmacist at Well Life Medical, in Peabody, MA, and other fellow leaders in the field of diabetes as they tackle some of the challenges we face when treating T2D. Topics of discussion include the disease state of T2D, the role of GLP-1 in glucose regulation, guidelines on early use of GLP-1 RAs in T2D treatment, as well as the mechanism of action, dosing and administration, efficacy and safety profiles, handling and storage, and education of patients and pharmacists for a once-daily GLP-1 RA for adults with T2D.
This podcast series is sponsored by Novo Nordisk and is intended for clinicians.
Could This GLP-1 RA be Right for Your Adult Patients With T2D?
The 411 on a GLP-1
25 minutes 15 seconds
1 month ago
Could This GLP-1 RA be Right for Your Adult Patients With T2D?
Join leaders in the field of diabetes, Dr. Jim Gavin, Dr. Pablo Mora, and Dr. Bob Busch, as they navigate through a clinical study. What do you need to know about using a GLP-1 RA for glycemic control with patients who have T2D? Are there any considerations for specific populations such as those who have moderate renal impairment?
The 411 on a GLP-1
Join series hosts Dr. Jim Gavin, Clinical Professor of Medicine at Emory University and Chief Medical Officer at Healing Our Village, in Atlanta, GA; Dr. Jennifer Goldman, Professor of Pharmacy at Massachusetts College of Pharmacy, in Boston, MA, and Clinical Pharmacist at Well Life Medical, in Peabody, MA, and other fellow leaders in the field of diabetes as they tackle some of the challenges we face when treating T2D. Topics of discussion include the disease state of T2D, the role of GLP-1 in glucose regulation, guidelines on early use of GLP-1 RAs in T2D treatment, as well as the mechanism of action, dosing and administration, efficacy and safety profiles, handling and storage, and education of patients and pharmacists for a once-daily GLP-1 RA for adults with T2D.
This podcast series is sponsored by Novo Nordisk and is intended for clinicians.
